Modulatory proteins can rescue a trafficking defective epileptogenic Nav1.1 Na+ channel mutant

被引:96
作者
Rusconi, Raffaella
Scalmani, Paolo
Cassulini, Rita Restano
Giunti, Giulia
Gambardella, Antonio
Franceschetti, Silvana
Annesi, Grazia
Wanke, Enzo
Mantegazza, Massimo
机构
[1] Besta Neurol Inst, Dept Neurophysiopathol, I-20133 Milan, Italy
[2] Milano Bicocca Univ, Dept Biosci & Biotechnol, I-20126 Milan, Italy
[3] Magna Graecia Univ Catanzaro, Inst Neurol, I-88100 Catanzaro, Italy
[4] CNR, Inst Neurol Sci, I-87050 Mongone, Italy
关键词
sodium; current; epilepsy; excitability; trafficking; GEFS; SMEI; seizure; SCN1A;
D O I
10.1523/JNEUROSCI.3515-07.2007
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Familial epilepsies are often caused by mutations of voltage-gated Na+ channels, but correlation genotype-phenotype is not yet clear. In particular, the cause of phenotypic variability observed in some epileptic families is unclear. We studied Na(v)1.1 (SCN1A) Na+ channel alpha subunit M1841T mutation, identified in a family characterized by a particularly large phenotypic spectrum. The mutant is a loss of function because when expressed alone, the current was no greater than background. Function was restored by incubation at temperature <30 degrees C, showing that the mutant is trafficking defective, thus far the first case among neuronal Na+ channels. Importantly, also molecular interactions with modulatory proteins or drugs were able to rescue the mutant. Protein-protein interactions may modulate the effect of the mutation in vivo and thus phenotype; variability in their strength may be one of the causes of phenotypic variability in familial epilepsy. Interacting drugs may be used to rescue the mutant in vivo.
引用
收藏
页码:11037 / 11046
页数:10
相关论文
共 54 条
[1]   Regulation of the voltage-gated cardiac sodium channel Nav1.5 by interacting proteins [J].
Abriel, H ;
Kass, RS .
TRENDS IN CARDIOVASCULAR MEDICINE, 2005, 15 (01) :35-40
[2]   Most LQT2 mutations reduce Kv11.1 (hERG) current by a class 2 (trafficking-deficient) mechanism [J].
Anderson, CL ;
Delisle, BP ;
Anson, BD ;
Kilby, JA ;
Will, ML ;
Tester, DJ ;
Gong, QM ;
Zhou, ZF ;
Ackerman, MJ ;
January, CT .
CIRCULATION, 2006, 113 (03) :365-373
[3]   Two novel SCN1A missense mutations in generalized epilepsy with febrile seizures plus [J].
Annesi, G ;
Gambardella, A ;
Carrideo, S ;
Incorpora, G ;
Labate, A ;
Pasqua, AA ;
Civitelli, D ;
Polizzi, A ;
Annesi, F ;
Spadafora, P ;
Tarantino, P ;
Candiano, ICC ;
Romeo, N ;
De Marco, EV ;
Ventura, P ;
LePiane, E ;
Zappia, M ;
Aguglia, U ;
Pavone, L ;
Quattrone, A .
EPILEPSIA, 2003, 44 (09) :1257-1258
[4]   Cellular biology of epileptogenesis [J].
Avanzini, G ;
Franceschetti, S .
LANCET NEUROLOGY, 2003, 2 (01) :33-42
[5]   Epileptogenic channelopathies: Experimental models of human pathologies [J].
Avanzini, Giuliano ;
Franceschetti, Silvana ;
Mantegazza, Massimo .
EPILEPSIA, 2007, 48 :51-64
[6]   Pharmacological chaperones:: potential treatment for conformational diseases [J].
Bernier, V ;
Lagacé, M ;
Bichet, DG ;
Bouvier, M .
TRENDS IN ENDOCRINOLOGY AND METABOLISM, 2004, 15 (05) :222-228
[7]   FRET between cardiac Na+ channel subunits measured with a confocal microscope and a streak camera [J].
Biskup, C ;
Zimmer, T ;
Benndorf, K .
NATURE BIOTECHNOLOGY, 2004, 22 (02) :220-224
[8]   From ionic currents to molecular mechanisms: The structure and function of voltage-gated sodium channels [J].
Catterall, WA .
NEURON, 2000, 26 (01) :13-25
[9]   International Union of Pharmacology. XLVII. Nomenclature and structure-function relationships of voltage-gated sodium channels [J].
Catterall, WA ;
Goldin, AL ;
Waxman, SG .
PHARMACOLOGICAL REVIEWS, 2005, 57 (04) :397-409
[10]   De novo mutations in the sodium-channel gene SCN1A cause severe myoclonic epilepsy of infancy [J].
Claes, L ;
Del-Favero, J ;
Ceulemans, B ;
Lagae, L ;
Van Broeckhoven, C ;
De Jonghe, P .
AMERICAN JOURNAL OF HUMAN GENETICS, 2001, 68 (06) :1327-1332